Scopio Labs secures $42 million in funding led by Fortissimo Capital

image credit- shutterstock

Scopio Labs, developer of Full-Field Digital Cell Morphology imaging and analysis platforms, announced the successful completion of its Series D funding round, raising $42 million. This round was led by Fortissimo Capital, with participation from existing investors. The newly secured capital is planned for commercial expansion and accelerating innovation of new products that leverage Scopio's Full-Field technology. This Series D brings Scopio's total fundraising to $130M.

Scopio's platform uses computational photography to provide unprecedented digital imaging of thousands of cells, enabling a full-field view of all regions of clinical interest on the sample at the highest resolution to lab practitioners, supplanting the need for manual microscopy. By using clinical AI-based decision support combined with full-field digital imaging, Scopio delivers unparalleled workflow efficiency in blood cell analysis designed to enhance remote consultation and collaboration, expedite decision-making, and bolster patient care. This platform not only amplifies diagnostic capabilities but also significantly curtails the time and expenses traditionally associated with manual methods.

The Series D funding will enable Scopio to accelerate its market penetration and expand its global footprint. This includes scaling sales and marketing efforts and strengthening customer support. The funding will support the continued development of Scopio Labs' digital morphology platform and the creation of next-generation products to meet the evolving needs of hematology laboratories and hospitals.